Establishment of multipotential and antigen presenting cell lines derived from myeloid leukemias in GM-CSF transgenic mice.
In this study neonatal mice expressing a GM-CSF transgene (GMT mice), and their normal littermate controls, were infected with Moloney murine leukemia virus (MoMLV) to examine in vivo tumorigenesis. By 200 days, all of the GMT mice had died whereas median survival had not been reached in the littermates (P < 0.0003). Thymomas developed in 32% of GMT mice and were more frequently CD4+CD8+ (83%) compared to the CD4+CD8- phenotype seen in 90% of thymomas developing in MoMLV-infected littermate mice. A primitive myeloid leukemia was induced in 21% of GMT mice, but none of the littermates. To characterize further the nature of the leukemic cells, a factor-dependent cell line (DGM36) was derived. DGM36 cells were tumorigenic, capable of differentiation to neutrophils, macrophages and eosinophils, and contained a partial deletion of chromosome 2. A subline arose spontaneously that was factor-independent and produced GM-CSF in an autocrine manner (IGM36 cells). Stimulation of the IGM36 cells with TNF alpha and IFNgamma resulted in increased expression of B7-1, class I MHC and class II MHC and consequent presentation of antigen in allogeneic MLRs. IGM36 cells thereby satisfy many of the criteria of dendritic cells and consequently may be used to examine antigen presentation by leukemic cells. This is the first report of primary myeloid leukemias arising in GMT mice and documents the derivation of a multipotential, autocrine leukemic cell line with dendritic cell characteristics.
Rasko
J E
JE
The Walter and Eliza Hall Institute of Medical Research, Victoria, Australia.
Metcalf
D
D
Alexander
B
B
Strasser
A
A
Begley
C G
CG
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology / Q000473:pathology*; D018929:Cell Culture Techniques / Q000379:methods; D002460:Cell Line; D002874:Chromosome Mapping; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000096:biosynthesis* / Q000235:genetics; D006412:Hematopoietic Stem Cells / Q000276:immunology / Q000473:pathology*; D007621:Karyotyping; D007942:Leukemia, Experimental / Q000276:immunology / Q000473:pathology*; D007951:Leukemia, Myeloid / Q000276:immunology / Q000473:pathology*; D007959:Lymphocyte Culture Test, Mixed; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008815:Mice, Inbred Strains; D008819:Mice, Nude; D016513:Mice, SCID; D008822:Mice, Transgenic; D008979:Moloney murine leukemia virus / Q000235:genetics; D009368:Neoplasm Transplantation; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D013945:Thymoma / Q000276:immunology / Q000473:pathology; D013953:Thymus Neoplasms / Q000276:immunology / Q000473:pathology
D016178:Granulocyte-Macrophage Colony-Stimulating Factor